Bioelectronics startup BackBeat Medical closed a $95M Series C to scale its implantable cardiac pacemaker-based system that reduces blood pressure without drugs — through precisely timed electrical pulses.
A new FDA-cleared device reads the spinal cord's electrical response in real time and adjusts its own stimulation parameters automatically — ending the era of manual pain device tuning.
Synchron has closed a $95M Series D to advance its minimally invasive brain-computer interface — a stent-like device implanted through a blood vessel that requires no open-brain surgery.
The FDA has granted Breakthrough Device Designation to a closed-loop spinal cord stimulator that automatically adjusts stimulation in real time based on neural feedback.
Medtronic's BrainSense Adaptive DBS system — cleared by the FDA in 2025 — is the first brain implant that reads neural signals in real time and adjusts its own stimulation accordingly. The era of closed-loop brain medicine has begun.
A wearable bioelectric patch delivering calibrated electrical fields to damaged tissue achieved healing rates three times faster than standard care in a Phase II trial.